You are here: Home / API / Antibiotics / Lincosamides Drugs / Lincomycin(154-21-2)C18H34N2O6S

Lincomycin(154-21-2)C18H34N2O6S

  • Chemical Name: Lincomycin
  • CAS No.:154-21-2
  • MF:C18H34N2O6S
  • MW:406.54
  • Purity:99% or according to customer requirements
  • Color:White
  • Product Categories: Antibiotics;APIs;Lincosamides Drugs;Intermediates & Fine Chemicals;Pharmaceuticals
  • Test method: HPLC
Availability:

What is Lincomycin?

Lincomycin is a lincosamide antibiotic derived from bacteria Streptomyces lincolnensis with activity against gram positive and anaerobic bacteria. Lincomycin binds to the 50S subunit of the bacterial ribosome resulting in the inhibition of protein synthesis and thereby produces bactericidal effects in susceptible organisms. (Source: NCI Thesaurus (NCIt))

Basic information
           
Product Name: Lincomycin
Synonyms: Lincomycinum; Lincomicina; Lincomycin A; Cillimycin; Lincomycine
CAS: 154-21-2
MF: C18H34N2O6S
MW: 406.54
EINECS: 205-824-6
Product Categories: Antibiotics;APIs;Lincosamides Drugs;Carbohydrates & Derivatives;Intermediates & Fine Chemicals;Pharmaceuticals
Chemical Structure

Lincomycin          

Chemical Properties  
Melting point  148-150°C
Boiling point  646.8±55.0 °C(Predicted)
density  1.1704 (rough estimate)
refractive index  1.6510 (estimate)
pka 7.6(at 25℃)
Usage And Synthesis

Lincomycin Uses           

Respiratory tract infections caused by Staphylococcus, Streptococcus pyogenes, pneumococcus and anaerobic bacteria, skin and soft tissue infections, female reproductive tract and pelvic infections, and abdominal cavity infections caused by anaerobic bacteria. In addition to the above indications, lincomycin injection can still be used for sepsis caused by streptococcus and staphylococcus, bone and joint infections, surgical adjuvant treatment of chronic bone and joint infections, and acute blood-borne bone marrow caused by staphylococci Yan etc. The concentration of lincomycin that penetrates into the cerebrospinal fluid cannot reach an effective level and is not suitable for the treatment of meningitis.



Lincomycin Veterinary 

Lincomycin has dosage forms approved for use in dogs, cats, swine, and in combination with other agents for chickens. Because clindamycin is generally better absorbed, more active, and probably less toxic, it has largely supplanted the use of lincomycin for oral and injectable therapy in small animals, but some clinicians believe that clindamycin does not offer enough clinically significant improvements over lincomycin to justify its higher cost. For further information, refer to the Pharmacology or Doses sections.


Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

MSDS: MSDS available.

COA: COA can be available if you send us inquiry.

Email us at: info@maxmedchem.com for more details.


packagingpacking&shipping

LEAVE MESSAGE

Active Pharmaceutical Ingredients (APIs)& Pharma intermediates Supplier

MAPS

ABOUT US

Maxmedchem Corporation, was founded in 2004 and is the one of top manufacturers of Active Pharmaceutical Ingredients (APIs), and intermediates.

CONTACT US

Add : 1901 S.Lynx Place, Ontario, CA 91761
Phone : +16263716327
Copyright © 2021 MAXMEDCHEM Co. Ltd. All rights reserved. | Sitemap